MedTrace Logo

A Digital Solution for Breast Cancer Patients

NCT05459454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2025-05-25

No results posted yet for this study

Summary

Sidekick Health has developed an interactive digital health program (SK-421) to support breast cancer patients. The study will be a single center pilot study with an intervention group and a comparison group aiming to recruit 66 breast cancer patients prescribed to surgery, chemotherapy, radiation and/or hormonal therapy according to standard breast cancer treatment.

This pilot study will determine whether the digital health program, supporting lifestyle changes, can positively impact management of side effects, quality of life, physical activity and fitness and medication adherence in this patient population.

Patients will be randomized to receive either the standard of care (SoC) treatment alone or SoC with the addition of the digital healthprogram.

Conditions

Interventions

DEVICE

A digital health program for patients with Breast Cancer

A digital solution that supports healthy lifestyle changes, provides disease and side effect education as well as daily tasks for patients diagnosed with breast cancer.

Sponsors & Collaborators

  • Landspitali University Hospital

    collaborator OTHER

  • Ljósið Cancer Rehabilitation Center

    collaborator UNKNOWN

  • Sidekick Health

    lead INDUSTRY

Principal Investigators

  • Sigríður L Guðmundsdóttir, PhD · Sidekick Health & University of Iceland

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-15
Primary Completion
2023-10-01
Completion
2024-04-01

Countries

  • Iceland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05459454 on ClinicalTrials.gov